InvestorsHub Logo
Followers 46
Posts 2450
Boards Moderated 0
Alias Born 04/17/2019

Re: None

Thursday, 10/22/2020 12:59:57 AM

Thursday, October 22, 2020 12:59:57 AM

Post# of 233754
I previously outlined how I thought leronlimab's disruption of the mTOR pathway could act as an antiviral by stopping virus splitting. Disruption of mTOR also downregulates neuropilin-1. So now we know of 2 and possibly 3 ways leronlimab acts against the virus.

SARS-CoV-2 Uses a Second Receptor, Neuropilin-1, to Infect Human Cells



https://www.genengnews.com/news/sars-cov-2-uses-a-second-receptor-neuropilin-1-to-infect-human-cells/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News